Preterm birth is defined as the birth of an infant between 20 weeks 0 days and 36 weeks 6 days ofgestation. Deliveries that are early by five weeks or more are the leading cause of infant morbidity and mortality in the United States. Progesterone is known to have an inhibitory effect o...
Hydroxyprogesterone caproate 快速询单 CAS No.:630-56-8 分子式:C27H40O4 分子量:428.6041 别名:己酸羟孕酮;长效黄体酮;己酸孕酮;17α-羟基孕酮己酸盐;17alpha-Hydroxyprogesterone Caproate 17α-羟基孕酮己酸盐;己酸孕酮 USP标准品;己酸孕酮(长效黄体酮);17α-羟基孕甾-4-烯-3,20-二酮己酸酯;羟孕酮己酸酯...
英文名称17a-Hydroxyprogesterone caproate 生化机理具有抗癌和抗炎特性的抗雌激素。作用于孕激素受体。 储存温度2-8°C储存 运输条件冰袋运输 作用类型激动剂 作用机制孕酮受体激动剂 备注如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的...
CAS号:630-56-8 MDL号: 分子式:C27H40O4 分子量:428.61 g/mol COAMSDS大包装询价 库存状态为分装好的现货产品(1.2.3...等具体数量),每日16:00前订单当天发出; 库存状态为未分装好的现货产品(显示 “现货” 字样),每日15:00前的订单1-3个工作日发出; 若小...
Perfusion of 17-alpha-hydroxyprogesterone caproate (17HPC) via the maternal circuit of a dually perfused human placental lobule resulted in the extensive formation of 2 metabolites. On the other hand, human placental microsomes biotransformed 17HPC into 5 monohydroxylated metabolites, which did not co...
Currently, despite more than half a century, 17-alpha hydroxyprogesterone caproate still has not been found to be clearly effective. In this context, how does the advising physician dependent on scientific evidence advise a patient that 17-alpha hydroxyprogesterone caproate is effective when the ...
List of Drug Master Files (DMF) of 17alpha-Hydroxyprogesterone n-caproate Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website
The aim was to determine whether progesterone (P4) or 17-alpha-hydroxyprogesterone caproate (17P) directly inhibit human uterine contractility in vitro and thereby clarify their mechanisms of action. Myometrial tissues were suspended in organ chambers and exposed for 2 to 20 hours to varying concen...
Cohen MR, Dresner MH, Frank R, Gold JJ (1956) The use of a new long- acting progestational steroid (17-alpha-hydroxyprogesterone caproate) in the therapy of secondary amenorrhea; a preliminary report. Am J Obstet Gynecol 72: 1103-1115....
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348(24):2379-2385. PubMedGoogle ScholarCrossref 2. Armstrong J. Unintended consequences–the cost of preventing preterm births after FDA approval of a branded version of 17OHP. N Engl J ...